HomeNewsTrendsHealthCoronavirus pandemic | Community transmission has started in some areas: AIIMS Delhi director
Trending Topics

Coronavirus pandemic | Community transmission has started in some areas: AIIMS Delhi director

When asked about the chances of the 21-day nationwide lockdown being extended, Dr Randeep Guleria said there would be no clarity on the situation till April 10

April 06, 2020 / 18:31 IST
Story continues below Advertisement
AIIMS Director Dr Randeep Guleria
AIIMS Director Dr Randeep Guleria

The Director of the All India Institute of Medical Sciences (AIIMS), New Delhi, believes the novel coronavirus outbreak in India might have reached Stage 3 in some pockets of the country, meaning, in these areas, community transmission has started taking place.

An India Today report quoting Dr Randeep Guleria’s interview to Aaj Tak stated that though India is largely still in Stage 2 of the outbreak, in certain areas of Mumbai, cases of localised community transmission have been noted.

Story continues below Advertisement

For live updates on coronavirus, click here

Adding that India is in between Stage 2 and Stage 3 of the outbreak right now, Guleria said if the spread of the highly contagious disease can be stopped in the hotspots right away, we can prevent slipping into Stage 3.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show